DAJY(002030)2024-01-09 13:56Group 1: Company Overview - Guangzhou Da'an Gene Co., Ltd. primarily focuses on product sales, with services accounting for a small proportion of its business [1] - The company has transitioned from ICL testing services, which were excluded from consolidated financial statements since October 2018 [1] - Da'an Gene has become a leading enterprise in the domestic molecular diagnostics industry after nearly 30 years of operation [2] Group 2: Industry Trends - The in vitro diagnostics (IVD) industry is evolving towards precision and personalization, driven by technological advancements and deeper disease understanding [2] - The company’s business encompasses various fields, including immunodiagnostics, biomedical technology, clinical applications, and food safety [2] Group 3: Competitive Advantages - Da'an Gene's competitive edge lies in its R&D capabilities, certification abilities, and product quality, along with unique product characteristics [2] - The company employs a direct sales model and has established long-term stable partnerships with hospitals and independent laboratories [2] Group 4: Investment Strategy - The company follows a "main business development + industry incubation" strategy, creating an industrial ecosystem to promote its main business and investment activities [2] - Da'an Gene has successfully incubated several companies, including Anjisi Medical Technology Co., Ltd., which went public on the Sci-Tech Innovation Board [2]